LFM
LGT Fund Management Portfolio holdings
AUM
$1.14B
This Quarter Return
+2.58%
1 Year Return
+24.1%
3 Year Return
+107.41%
5 Year Return
–
10 Year Return
–
AUM
$1.14B
AUM Growth
+$1.14B
(+19%)
Cap. Flow
+$170M
Cap. Flow
% of AUM
14.88%
Top 10 Holdings %
Top 10 Hldgs %
32.74%
Holding
268
New
50
Increased
96
Reduced
50
Closed
20
Top Buys
| 1 |
Blackrock
BLK
|
$20.1M |
| 2 |
Broadcom
AVGO
|
$11.1M |
| 3 |
Booking.com
BKNG
|
$10.2M |
| 4 |
PayPal
PYPL
|
$10.1M |
| 5 |
Amazon
AMZN
|
$9.17M |
Top Sells
| 1 |
3M
MMM
|
$12.9M |
| 2 |
Pfizer
PFE
|
$11.6M |
| 3 |
Nike
NKE
|
$9.28M |
| 4 |
B
Barrick Mining Corporation
B
|
$5.19M |
| 5 |
Merck
MRK
|
$4.77M |
Sector Composition
| 1 | Technology | 27.08% |
| 2 | Financials | 21.11% |
| 3 | Consumer Discretionary | 12.49% |
| 4 | Healthcare | 11.61% |
| 5 | Communication Services | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Merck
MRK
$210B
| $5.46M | 0.48% |
54,897
-47,965
| -47% | -$4.77M |
|
52
Advanced Micro Devices
AMD
$264B
| $5.36M | 0.47% |
44,368
+3,000
| +7% | +$362K |
|
53
Citigroup
C
$178B
| $5.28M | 0.46% |
75,028
+5,460
| +8% | +$384K |
|
54
T-Mobile US
TMUS
$284B
| $5.24M | 0.46% |
23,733
+11,987
| +102% | +$2.65M |
|
55
Thermo Fisher Scientific
TMO
$186B
| $5.22M | 0.46% |
10,034
+702
| +8% | +$365K |
|
56
Roper Technologies
ROP
$56.6B
| $5.21M | 0.46% |
10,014
+2,146
| +27% | +$1.12M |
|
57
Canadian Pacific Kansas City
CP
$69.9B
| $5.16M | 0.45% |
71,338
-1,868
| -3% | -$135K |
|
58
Ametek
AME
$42.7B
| $5.06M | 0.44% |
28,095
+5,781
| +26% | +$1.04M |
|
59
PepsiCo
PEP
$204B
| $4.9M | 0.43% |
32,243
-2,000
| -6% | -$304K |
|
60
Equifax
EFX
$30.3B
| $4.52M | 0.4% |
+17,729
| New | +$4.52M |
|
61
Exxon Mobil
XOM
$487B
| $4.18M | 0.37% |
38,859
-801
| -2% | -$86.2K |
|
62
Stellantis
STLA
$27.8B
| $4.11M | 0.36% |
315,264
+22,639
| +8% | +$295K |
|
63
Intuit
INTU
$186B
| $3.98M | 0.35% |
6,337
+997
| +19% | +$627K |
|
64
Agnico Eagle Mines
AEM
$72.4B
| $3.81M | 0.33% |
48,800
-2,900
| -6% | -$227K |
|
65
Colgate-Palmolive
CL
$67.9B
| $3.8M | 0.33% |
41,756
+31,179
| +295% | +$2.83M |
|
66
Aon
AON
$79.1B
| $3.78M | 0.33% |
10,533
-690
| -6% | -$248K |
|
67
AbbVie
ABBV
$372B
| $3.77M | 0.33% |
21,239
+17,188
| +424% | +$3.05M |
|
68
EOG Resources
EOG
$68.2B
| $3.76M | 0.33% |
30,641
+689
| +2% | +$84.5K |
|
69
Chemours
CC
$2.31B
| $3.64M | 0.32% |
215,481
+23,553
| +12% | +$398K |
|
70
Teva Pharmaceuticals
TEVA
$21.1B
| $3.56M | 0.31% |
+161,447
| New | +$3.56M |
|
71
Danaher
DHR
$147B
| $3.37M | 0.3% |
14,699
+1,328
| +10% | +$305K |
|
72
Bristol-Myers Squibb
BMY
$96B
| $3.34M | 0.29% |
59,088
+3,338
| +6% | +$189K |
|
73
Accenture
ACN
$162B
| $3.34M | 0.29% |
9,497
-120
| -1% | -$42.2K |
|
74
Vital Farms
VITL
$2.28B
| $3.13M | 0.27% |
+83,162
| New | +$3.13M |
|
75
Copart
CPRT
$47.2B
| $3.06M | 0.27% |
53,300
-30,000
| -36% | -$1.72M |
|